176 related articles for article (PubMed ID: 34983303)
1. DEP domain containing 1B (DEPDC1B) exerts the tumor promoter in hepatocellular carcinoma through activating p53 signaling pathway via kinesin family member 23 (KIF23).
Shen E; Zhang J; Lu Y
Bioengineered; 2022 Jan; 13(1):1103-1114. PubMed ID: 34983303
[TBL] [Abstract][Full Text] [Related]
2. Overexpressed DEPDC1B contributes to the progression of hepatocellular carcinoma by CDK1.
Dang XW; Pan Q; Lin ZH; Wang HH; Li LH; Li L; Shen DQ; Wang PJ
Aging (Albany NY); 2021 May; 13(16):20094-20115. PubMed ID: 34032605
[TBL] [Abstract][Full Text] [Related]
3. [MicroRNA 424-5p promotes the sensitivity of hepatocellular carcinoma cells to sorafenib by targeting Kinesin family member 23].
Liu XL; Sun CF; Yuan Y; Sheng YJ; Deng CL
Zhonghua Gan Zang Bing Za Zhi; 2022 Oct; 30(10):1074-1081. PubMed ID: 36727232
[No Abstract] [Full Text] [Related]
4. DEPDC1B is involved in the proliferation, metastasis, cell cycle arrest and apoptosis of colon cancer cells by regulating NUP37.
Xiong H; Li Y; Liu M
Mol Med Rep; 2023 Jun; 27(6):. PubMed ID: 37203403
[TBL] [Abstract][Full Text] [Related]
5. FOXM1 augments sorafenib resistance and promotes progression of hepatocellular carcinoma by epigenetically activating KIF23 expression.
Zhu C; Guo H; Ma Z; Shi S; Zhao X; Zhai D; Zhou X; Jiang P; Xu Q; Cai J
Biochem Biophys Res Commun; 2023 May; 656():1-9. PubMed ID: 36940637
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of KIF23 variant 1 expression and relevance as a novel prognostic factor in patients with hepatocellular carcinoma.
Sun X; Jin Z; Song X; Wang J; Li Y; Qian X; zhang Y; Yin Y
BMC Cancer; 2015 Dec; 15():961. PubMed ID: 26674738
[TBL] [Abstract][Full Text] [Related]
7. A Therapeutically Targetable TAZ-TEAD2 Pathway Drives the Growth of Hepatocellular Carcinoma via ANLN and KIF23.
Saito Y; Yin D; Kubota N; Wang X; Filliol A; Remotti H; Nair A; Fazlollahi L; Hoshida Y; Tabas I; Wangensteen KJ; Schwabe RF
Gastroenterology; 2023 Jun; 164(7):1279-1292. PubMed ID: 36894036
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
[TBL] [Abstract][Full Text] [Related]
9. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
Guo W; Li H; Liu H; Ma X; Yang S; Wang Z
Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
[TBL] [Abstract][Full Text] [Related]
10. A putative novel protein, DEPDC1B, is overexpressed in oral cancer patients, and enhanced anchorage-independent growth in oral cancer cells that is mediated by Rac1 and ERK.
Su YF; Liang CY; Huang CY; Peng CY; Chen CC; Lin MC; Lin RK; Lin WW; Chou MY; Liao PH; Yang JJ
J Biomed Sci; 2014 Aug; 21(1):67. PubMed ID: 25091805
[TBL] [Abstract][Full Text] [Related]
11. DEPDC1B promotes colorectal cancer via facilitating cell proliferation and migration while inhibiting apoptosis.
Han F; Cheng C; Xu Q; Chen J; Yang Z; Liu J
Cell Cycle; 2023 Jan; 22(1):131-143. PubMed ID: 36016512
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma.
Wang SM; Ooi LL; Hui KM
Clin Cancer Res; 2011 Sep; 17(18):6040-51. PubMed ID: 21825042
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-24 increases hepatocellular carcinoma cell metastasis and invasion by targeting p53: miR-24 targeted p53.
Chen L; Luo L; Chen W; Xu HX; Chen F; Chen LZ; Zeng WT; Chen JS; Huang XH
Biomed Pharmacother; 2016 Dec; 84():1113-1118. PubMed ID: 27780140
[TBL] [Abstract][Full Text] [Related]
14. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
15. SEPT6 drives hepatocellular carcinoma cell proliferation, migration and invasion via the Hippo/YAP signaling pathway.
Fan Y; Du Z; Ding Q; Zhang J; Op Den Winkel M; Gerbes AL; Liu M; Steib CJ
Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33846777
[TBL] [Abstract][Full Text] [Related]
16. DEP domain containing 1 predicts prognosis of hepatocellular carcinoma patients and regulates tumor proliferation and metastasis.
Qu D; Cui F; Lu D; Yang Y; Xu Y
Cancer Sci; 2019 Jan; 110(1):157-165. PubMed ID: 30417471
[TBL] [Abstract][Full Text] [Related]
17. GTSE1 promotes cell migration and invasion by regulating EMT in hepatocellular carcinoma and is associated with poor prognosis.
Wu X; Wang H; Lian Y; Chen L; Gu L; Wang J; Huang Y; Deng M; Gao Z; Huang Y
Sci Rep; 2017 Jul; 7(1):5129. PubMed ID: 28698581
[TBL] [Abstract][Full Text] [Related]
18. The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation.
Wang Y; Wang H; Yan Z; Li G; Hu G; Zhang H; Huang D; Wang Y; Zhang X; Yan Y; Lu Q; Cheng M; Luo S
Cell Commun Signal; 2020 Jul; 18(1):116. PubMed ID: 32723329
[TBL] [Abstract][Full Text] [Related]
19. Silencing GTSE-1 expression inhibits proliferation and invasion of hepatocellular carcinoma cells.
Guo L; Zhang S; Zhang B; Chen W; Li X; Zhang W; Zhou C; Zhang J; Ren N; Ye Q
Cell Biol Toxicol; 2016 Aug; 32(4):263-74. PubMed ID: 27240802
[TBL] [Abstract][Full Text] [Related]
20. DEPDC1B knockdown inhibits the development of malignant melanoma through suppressing cell proliferation and inducing cell apoptosis.
Xu Y; Sun W; Zheng B; Liu X; Luo Z; Kong Y; Xu M; Chen Y
Exp Cell Res; 2019 Jun; 379(1):48-54. PubMed ID: 30880030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
